Kakaire Kirunda
26 August 2008
Uganda is set to receive a grant of more than 300,000 Euros (about Shs690m) this year to prepare for a malaria vaccine trial by the faculty of medicine at Makerere University.
The money is to be sourced for by the African Malaria Network Trust (Amanet), the organisation's Managing Trustee, Prof Wen Kilama, announced this yesterday at the start of a training session on health research ethics for ethics committees and review boards in Africa.
"Sometime this year, we shall give them a grant for further capacity building towards the development of a new vaccine and against malaria called GMZ2. That grant is worth over 300,000 Euros," Prof Kilama disclosed without stating the exact figure.
Although no date has been fixed for the latest grant signing, Prof Kilama said the money has been guaranteed.
Statistics show that malaria kills over 300 Ugandans per day, mostly children below five years of age and pregnant mothers.
Officiating at the start of the week-long training, the State Minister for Primary Health Care, Dr Emmanuel Otaala, said while it is quite a while since malaria vaccine trials started in Africa, hope is not lost.
He said whatever outcomes got will go a long way in improving the way HIV/Aids is looked at.
Be the first to Write a Comment!
Copyright © 2008 The Monitor. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.
AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.
